Jessica Gates

If you are interested in women's health, meaningful applications of AI-enabled analytics in health care, or both - check out this new article by my awesome Real Chemistry colleagues, Britt McKone and Allison K. Marshall. They showcase the power of a more inclusive approach to social intelligence (especially when so many women feel unseen and unheard within our health care system). And they feature several case studies that illuminate how such social intelligence can unlock new strategies for manufacturers to help improve education, access, and (ideally) outcomes in women's health. https://lnkd.in/grXWRvEP

16

Many innovative ideas can become obscured when communicated, which was a significant challenge for Patient Blood Management #PBM as it was introduced to benefit those suffering from #anemia, in hopes of enabling surgery without the use of donated blood upon leaving the ER (Emergency Room). The PBM educational approach supports bloodless surgical procedures. To reduce this obscurity, we are simplifying the message and increasing awareness, benefiting #researchers, manufacturers, and healthcare practitioners. Most importantly, we are enhancing the patient experience and raising public awareness. We are confident that many global organizations, healthcare providers, and blood management surgical equipment manufacturers will support our efforts as we continue to be pioneers in building a bridge of engagement for public access, which will benefit this field of medicine. Remember our medical icons, just in case one day you need direction to the OR. #Bloodlines #BBTS #Blood #SABM

6

I've had some interesting discussions about thought leadership recently, and I want to make it clear: simply sharing your opinion does not make you a thought leader. Thought leadership is a strategic approach within a broader content strategy where companies and their leaders share their expertise and insights supported by data. According to Edelman, 73% of decision-makers consider an organization's thought leadership content, from both the company and its executives, a more reliable way to assess its capabilities and competencies than its marketing materials and product sheets. Additionally, 90% of decision-makers say they are moderately or very likely to be more open to sales or marketing outreach from a company that consistently produces high-quality thought leadership content. Thought leadership is not just about sharing your opinion, it's about creating a positive impression of your brand, product, and team. It's a tool that can build credibility and trust, enhance your company's reputation, and even shape industry discussions and trends. Most importantly, it can drive business growth. Are you ready to elevate your brand and drive business growth through thought leadership? Let me help you turn your ideas into impactful content. 🚀 >> For more insights from Edelman, visit https://lnkd.in/gAvpvD8P

8

🚀 Exciting New Episode Alert! 🎙️ Join us on the #WomenInMedtechPodcast as we dive deep into medtech innovation and authentic demand with insights from the book "The Heart of Innovation: A Field Guide for Navigating Authentic Demand." 🌟 In this episode, hosts Colleen Patterson, Barbara Strain, and Abby Norfleet explore the critical differences between genuine market needs and superficial wants. Discover how understanding your customers' true requirements can transform innovative ideas into indispensable solutions. 🏥💡 Whether you're a medtech enthusiast or a seasoned professional, this episode is packed with valuable insights that can help you navigate the ever-evolving landscape of medtech innovation. Don't miss out! Listen now and join the conversation. 👇 #MedTech #Innovation #Podcast #Healthcare #WomenInMedtech #AuthenticDemand #TheHeartOfInnovation #MedicalTechnology https://bit.ly/3z1QFC8

7

Evaluating pharmacy benefits is daunting. From the technical and clinical terms, the fast-moving health trends, to long list of fees, benefits managers currently have an uphill battle caring for their employees. We're here to clear all that up during this webinar. Join us to lighten the load! #hr #hrbenefits #benefits #pbm #pharmacy #pharmacybenefits #healthplan #costcontainment #totalrewards

10

HIGHLIGHT REEL I created a playlist of some of our favorite episodes about consumer innovation and leadership. These are some of our favorite interviews with CEOs and other senior leaders who are prioritizing consumer experience and engagement from some of the largest and most respected brands in the industry. The fact that we've been able to secure rock star guests like this tells me that the industry is more interested in learning about consumer innovations than ever before. Hope you enjoy. Healthcare Rap Podcast Shift Forward Health Zain Ismail James A. Gardner #healthcare #leadership #consumerhealth #retailhealth #digitalhealth #podcast

59

4 Comments

😂Enrollment is a joke! 𝐓𝐡𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐬 𝐬𝐨 𝐛𝐥𝐢𝐧𝐝𝐞𝐝 𝐭𝐡𝐚𝐭 𝐢𝐭 𝐬𝐚𝐛𝐨𝐭𝐚𝐠𝐞𝐬 𝐞𝐧𝐫𝐨𝐥𝐥𝐦𝐞𝐧𝐭 𝐰𝐢𝐭𝐡 𝐨𝐮𝐭𝐝𝐚𝐭𝐞𝐝, 𝐢𝐧𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐦𝐞𝐭𝐡𝐨𝐝𝐬. Stop the charade— if we truly cared about progress, enrollment wouldn't be a joke. We need a system built on: 🔹𝐌𝐨𝐝𝐞𝐫𝐧 𝐄𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭: Utilize innovative strategies that resonate with today's patients. 🔹𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 & 𝐓𝐫𝐮𝐬𝐭: Clearly communicate trial information and build strong patient relationships. 🔹𝐀𝐜𝐜𝐞𝐬𝐬𝐢𝐛𝐢𝐥𝐢𝐭𝐲 & 𝐅𝐥𝐞𝐱𝐢𝐛𝐢𝐥𝐢𝐭𝐲: Design trials that fit seamlessly into patients' lives. Let's move beyond the status quo. Together, we can revolutionize clinical research. Visit https://lnkd.in/eBHqfcG3 to learn more and get involved. Ina Burgstaller #clinicalresearch #clinicaltrials #patientenrollment

4

Who knows when a DCT approach will be best for patients AND trial outcomes? Sites are a pretty safe bet. And, they night have some good perspective on how to implement these elements. In Dan Schell's latest Clinical Leader column, he sits down with Noelle Gaskill, MBA, ACRP-CP and explores her experience with designing and executing hybrid trials. #clinicalresearch #clinicaltrials #DCT

5

Most people don't realize that oncology practices spend millions of dollars to purchase innovative cancer drugs, and are only reimbursed weeks and often months after the drugs are administered. What's worse is each insurance plan (a practice can deal with 100+ different plans) reimburses at a different rate, so the practice really doesn't know if it's even going to be fully reimbursed at the time treatment decisions are made. These dynamics stack the odds against oncology providers, who just want to provide the best care for patients. But as with all things, there is power in data! AC3 #IntelRx

22

1 Comment

Great new insight from our Pivotal Analytics team. We spend a lot of time preaching about the value of localized data and this infographic is great way to see that in action - demand for Cardiology varies a LOT on a market-to-market basis. Utilizing claims data as an input allows us to tailor insight to a local population, something we see far too few people doing on a regular basis - I continue to be surprised how many strategy leaders rely on demand intel driven by national benchmarks.

7

Here is Michele Dunleavy with another great PM tip of the day. This one is all about team organization and togetherness! #ArtemisFactor #TipoftheDay #WeeklyMeetings #HealthcareInnovation #PharmaLeadership #ProjectManagement #WomenOwnedBusiness

11

Education is key to helping patients with chronic, progressive conditions like multiple sclerosis understand the different therapy regimens they’ll take over the course of treatment. In a recent interview with Pharmacy Times, Megan Schneider, PharmD, talks about pharmacists’ role in impacting medication adherence and the high stakes of patient engagement to these complex, high-touch medications.  Listen below 🎧 https://lnkd.in/gGEQ5k72 

26

We predicted a large and growing #autoimmune market a decade ago and invested time to do over 500 patient interviews to better understand the needs of our patients. Now at rheumission we have an effective way to address a #Rheumatology patient's needs including an autoimmune dietician, psychologist, and care coordinator, guided by both a #rheumatologist and #lifestyle medicine physician. Curious to learn how we are creating a "Patient First" approach at the forefront of #Integrative #Rheumatology see www.rheumission.com. #healthcareonlinkedin #startup #rheumatology #V1C #autoimmune #integrativemedicine #rheumatoid #arthritis #psoriatic #arthritis

9

Getting ready for #ASCO24? So is Real Chemistry. Check out our latest report on how the #healthcare industry can more effectively use social media to promote early #cancer screenings in young adults.

7

With #FathersDay approaching, we asked #medtech leaders how fathers and fatherhood have made them better leaders. Check out the results. #meddevice #leadership

2

The latest episode in our #WPOPerspectives series sees Dr Nkem Okeke, MD, MPH, MBA, MSPM, founder and owner of Medicalincs, in conversation with Kelly Mathews, founder and past president of KSM. Nkem says that what many fail to realize when they see someone’s success is that it is the result of incredibly hard work and dedication. You can view this episode and all previous episodes here: https://lnkd.in/dHfishfp #WomenEntrepreneurs #WomenInBusiness #WomenSuccess #WomenPresidentsOrganization

15

2 Comments

Check out Episode 4 of CTI’s Moving Medicine Forward Podcast at https://lnkd.in/g7bUDhfX or connect with Katie on LinkedIn to learn how we are advancing the field of CGT. Meet Katie Westerkamp | Associate Director, Therapeutic Strategy Lead CTI is a leader in Cell and Gene Therapy (CGT) with experts like Katie driving innovative healthcare solutions. - What got you into CGT Research? “My first gene modified cellular therapy program was with beta thalassemia patients. The passion, particularly from Study Coordinators, made a lasting impact on driving my career in Cell and Gene research. I’m proud to pave the operational plan for CTI’s Cell and Gene Therapy studies, along with heading our Cell and Gene Therapy Center of Excellence.” - Where do you see the future of CGT? “The safety profile for Cell and Gene Therapy products has become more manageable based on knowledge we have gained. Traditionally, approved therapy centers sat within academic institutions. With an improved safety profile and consistent FDA approvals, there is a need for those products to move into regional and community hospitals. With the correct training protocols, this increases access to patients who otherwise wouldn’t have these products available to them within a reasonable radius of their home.” #MovingMedicineForward #AdvancingHealthcareSolutions #CRO #ThinkGlobalActLocal #CRC #CellTherapy #GeneTherapy #EmployeeSpotlight #CTIFamily 

21

From neurology to oncology and everything in between, the WMW team has expertise across a variety of therapeutic areas. What can we do to support your medical communications efforts? Learn more at www.wiesenmed.com #medicalwriting #medicalcommunications #medicalaffairs #neurology #oncology

6

A recent survey reveals mixed feelings among healthcare professionals on corporate brand marketing in #pharma. When launching a campaign, physicians want companies to focus on delivering facts for the patient rather than building emotional connections. Dive deeper into the findings here: https://bit.ly/3UPHlIQ

2